Home > PE Ratio > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
PE (Price/Earnings) Ratio

The Current P/E Ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is -19.16.

Share Price ₹214.6May 13,2024
Market Cap ₹6,962.1 Cr
Earnings-TTM₹-363.4 CrTTM-Standalone Results
Price/Earnings-19.16xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of SUN PHARMA ADVANCED RESEARCH COMPANY

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is calculated as :

Current Market Cap [ ₹6,962.1 Cr] as on May 13,2024

(/) Earnings [ ₹-363.4 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ -19.16x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SUN PHARMA ADVANCED RESEARCH COMPANY , the investors are currently willing to pay -19.16 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SUN PHARMA ADVANCED RESEARCH COMPANY !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SUN PHARMA ADVANCED RESEARCH COMPANY over the last five years.

Historical PE (Price/Earnings) ratio chart of SUN PHARMA ADVANCED RESEARCH COMPANY


PE Ratio Performance Analysis for SUN PHARMA ADVANCED RESEARCH COMPANY

- SUN PHARMA ADVANCED RESEARCH COMPANY 's latest p/e ratio is -19.16x.

- SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.00x.

- SUN PHARMA ADVANCED RESEARCH COMPANY 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio peaked in Mar2023 at 0x.

- SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does SUN PHARMA ADVANCED RESEARCH COMPANY 's P/E Ratio benchmark against top 10 peers in Business Support Industry?

Peer Comparison (Business Support Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SUN PHARMA ADVANCED RESEARCH COMPANY -363.41-19.166,962.1
SYNGENE INTERNATIONAL LTD510.0053.2527,157.2
LATENT VIEW ANALYTICS LTD158.6459.539,444.0
JUST DIAL LTD362.9323.568,550.0
DREAMFOLKS SERVICES LTD75.9635.292,680.5
EKI ENERGY SERVICES LTD-129.20-6.76873.3
AGS TRANSACT TECHNOLOGIES LTD-91.01-9.25841.9
JAYKAY ENTERPRISES LTD10.0879.51801.5
QUINT DIGITAL LTD47.769.11435.3
PTL ENTERPRISES LTD20.4626.99552.3
SWADESHI POLYTEX LTD94.9914.661,392.7

Business Support Industry Benchmark (Top 10) PE Analysis vs SUN PHARMA ADVANCED RESEARCH COMPANY 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -19.16x
Max industry PE 79.51x
Median industry PE 23.56x
Average industry PE 24.25x



You may also like the below Video Courses